Bromocriptine has an accepted place in the management of small pituitary tumours that secrete either prolactin or growth hormone. The treatment of large tumours with extrasellar extensions is more difficult, however: though surgery is the standard treatment, it is often unsuccessful in returning excessive hormone secretion to normal and may cause hypopituitarism. A prospective trial was undertaken to assess the frequency with which changes in pituitary function and size of large tumours occurs. Nineteen patients were studied before and during treatment with bromocriptine (7-5 to 60 mg/day) for three to 
Proportions of girls aged 10-14 who had reached menarche according to whether they were thin and indulged in intensive sports activity°' 
Discussion
Our data are compatible with the hypothesis that both thinness and physical activity may cause delayed menarche. In addition, the effects of these two factors seem synergistic5: several girls who would have reached menarche if either thinness or intensive sports activity had been present alone had not reached menarche when both factors were present together. Since metabolic changes are probably associated with sports activity and with thinness, synergism of the effects makes sense.
One objection to our analysis is that a certain body mass index might not have the same meaning in a person who is physically active as in a person who is not, owing to different lean:fat ratios. We have no means to correct for this in our data. Other possible objections might be that in subjects aged 10-14 the body mass index rises with age, and that at this critical age drastic changes in physical activity might occur. To take such confounding influences into account we performed the analysis again with smaller age groups, halving the five-year age category. The synergistic relation persisted in each of the two resulting age groups. On finer stratification by single years of age the gradient between the thin and not-thin and sports and no-sports categories remained in the same direction, though the smallness of the numbers made it difficult to judge synergy confidently. Thus our data reinforce and refine the earlier hypotheses of Frisch et al,' 2 particularly since the information was collected during a population survey without obvious selection and without advance knowledge about the factors entailed in the hypotheses.
Introduction
Bromocriptine, a long-acting dopamine agonist, lowers abnormal circulating hormone concentrations in patients with small pituitary tumours that secrete prolactin and growth hormone, and it has an accepted place in their management.'6 The best treatment for large pituitary tumours that extend out of the sella turcica, however, is more difficult and controversial. Mostly, these tumours secrete prolactin though they may be truly nonfunctioning or, more rarely, secrete either growth hormone or adrenocorticotrophin.7 Urgent surgical decompression is normally recommended if the tumour extends upwards tc afIect the visual pathways or laterally to affelt the oculomotor nerve.
The operation may be performed using either the transfrontal or transsphenoidal routes, either of which is usually locally satisfactory, but both have a morbidity and hormonal cure is rare and hypopituitarism frequent.2 8 9 External pituitary irradiation is contraindicated in extensive extrasellar extension since further swelling may occur during treatment. Several reports suggest that prolactinomas and tumours associated with acromegaly may shrink with an improvement in pituitary hormonal state, and visual-field defects may improve in some patients,5 10-16 though the overall frequency of such beneficial responses is still not clear. It therefore seemed that dopamine agonist treatment should be considered in large extrasellar extensions to reduce the pituitary tumour mass in patients who would otherwise be submitted to urgent hypophysectomy.
We carried out a prospective collaborative trial in 19 consecutive patients to evaluate the incidence of a decrease in size of large tumours treated with bromocriptine alone. Pneumoencephalography or metrizamide cisternography were performed in addition to computed tomography (CT) to assess pituitary tumour size before and after at least three months of treatment. Assessment duiring treatment-All patients with a visual acuity of worse than 6/12 were monitored in hospital for two weeks, during which time visual acuity was measured daily and the fields were plotted weekly. Thereafter, fields were plotted monthly. Basal endocrine assessment was carried out at least monthly. A further complete re-evaluation was then performed in hospital after three months of treatment and at intervals thereafter. The contrast studies were reviewed by all the participants and only when there was unanimous agreement were the tumours reported as changing in size. If there was no evidence of a reduction in pituitary tumour size by three months, the patients were referred for surgical treatment. The patients were followed up for between three and 22 months (mean 7 6). (table II) . In 12 patients, including the one with the apparently non-functioning lesion, comparison of the contrast studies showed an unequivocal decrease in the size of the pituitary tumour; two others with equivocal shrinkage were not subjected to surgical exploration but were followed up for longer periods. The extrasellar extensions were completely eliminated in seven patients and in two of these a partially empty sella developed 16 MEDICINES APPROPRIATED TO THE REINS AND BLADDER-The office of the reins is, to make a separation between the blood and the urine; to receive this urine thus separated from the blood, is the bladder ordained, which is of a sufficient bigness to contain it. Both these parts of the body officiating about the urine, they are both usually afflicted by the vices of the urine. 1. By stones. 2. By inflammation. 3. By thick humours. Medicines appropriated to the reins and bladder are usually called Nephriticals, and are threefold; some cool, others cut gross humours, and a third sort breaks the stone.
In the use of all these, take notice, that the constitution of the reins and bladder is such, that they abhor all binding medicines because they cause stoppage of urine. Take notice, that the reins and bladder being subject to inflammations endure not very hot medicines. Because the bladder is further remote from the centre of the body than the kidnies are, therefore it requires stronger medicines than the kidnies do, lest the strength of the medicine be spent before it be come to the part afflicted. (Nicholas Culpeper (1616-54) The Complete Herbal, 1850.)
